Skip to main content
. 2006;8(Suppl 2):S35–S47.

Figure 4.

Figure 4

Five-year survival curves for 20 trials of androgen suppression plus nilutamide or flutamide versus androgen suppression alone, and 7 trials of androgen suppression plus cyproterone acetate versus androgen suppression alone. Reprinted from The Lancet, volume 355, Maximum androgen blockade in advanced prostate cancer: an overview of the randomized trials. Prostate Cancer Trialists’ Collaborative Group, pp. 1491–1498, copyright 2000, with permission from Elsevier.